Theratechnologies Accounts Payable

Theratechnologies (THTX) currently reports a accounts payable of $23M as of May 2025. That compares with $26M in the prior-year period — down 12.1% year over year. Use the charts on this page to explore Theratechnologies's accounts payable history and peer comparisons.

Theratechnologies's accounts payable decreased from $26M to $23M — a 12.1% year-over-year decrease (period ending May 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Theratechnologies reported $23M in accounts payable as of May 2025. That compares with $26M in the prior-year period — down 12.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Theratechnologies, and consider following THTX for alerts when major investors trade the stock.

Theratechnologies is classified in the Healthcare sector. On accounts payable, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing THTX with unrelated industries.